سعر جاست ريج 50 مجم/5مل 3 امبولات 2025

Trimebutine maleate 50 mg/5 ml solution for IV/IM injection (3 ampoules), a GI motility regulator; made in Egypt by Amoun.

• Symptomatic treatment of pain, transit disorders and intestinal discomfort related to functional bowel disorders when the oral route is not possible.ANSM - Base de données publique des médicaments

• Injection form, uncommon: lipothymia, syncope; frequency not known: abuse and dependence.International label, same formulation · ANSM - Base de données publique des médicaments
• Uncommon: rash. Frequency not known: hypersensitivity reactions (pruritus, urticaria, angioedema, exceptionally anaphylactic shock), generalized maculopapular eruption, erythema, eczema-like reactions and exceptionally severe skin reactions (AGEP, erythema multiforme).International label, same formulation · ANSM - Base de données publique des médicaments

• Hypersensitivity to trimebutine or any excipient.International label, same formulation · ANSM - Base de données publique des médicaments
• Children under 2 years of age.International label, same formulation · ANSM - Base de données publique des médicaments

• The French ampoule contains benzyl alcohol (25 mg per 5 mL): risk of hypersensitivity and of serious toxicity in neonates; avoid for more than 1 week in children under 3 years unless necessary; consider accumulation in hepatic/renal impairment and pregnancy. Check whether the Egyptian ampoule contains benzyl alcohol.International label, same formulation · ANSM - Base de données publique des médicaments

• French injection: as a precaution it is preferable not to use it during pregnancy (benzyl alcohol may cross the placenta; risk of accumulation and metabolic acidosis); no teratogenic effect of trimebutine in animals.International label, same formulation · ANSM - Base de données publique des médicaments
• French injection: avoid during breastfeeding (unknown trimebutine passage; benzyl alcohol may pass into milk).International label, same formulation · ANSM - Base de données publique des médicaments

• Trimebutine maleate: Modulates intestinal motility via peripheral opioid receptors.